Search research articles
Contact Us
Filters
Showing results (901-910 of 1,180) with videos related to
Page
of 118
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2015
The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer
Shuang G Zhao, Joseph R Evans, Vishal Kothari, et al.
Science (New York, N.Y.)
|
February 11, 2017
A switch from canonical to noncanonical autophagy shapes B cell responses
Nuria Martinez-Martin, Paula Maldonado, Francesca Gasparrini, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
G Akabani, I Cokgor, R E Coleman, et al.
Cancer
|
June 29, 2019
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database
Amandeep R Mahal, Santino Butler, Idalid Franco, et al.
NPJ Precision Oncology
|
October 2, 2024
A phenocopy signature of TP53 loss predicts response to chemotherapy
Hamza Bakhtiar, Marina N Sharifi, Kyle T Helzer, et al.
Oncogene
|
September 27, 2016
Cell cycle-coupled expansion of AR activity promotes cancer progression
C McNair, A Urbanucci, C E S Comstock, et al.
European Urology
|
June 2, 2018
The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer
Matthew R Cooperberg, Nicholas Erho, June M Chan, et al.
Molecular and Cellular Biochemistry
|
July 1, 1997
Construction of a human heart cDNA library and identification of cardiovascular based genes (CVBest)
C C Liew, D M Hwang, R X Wang, et al.
Prostate Cancer and Prostatic Diseases
|
May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer
S G Zhao, W C Jackson, V Kothari, et al.
Cancer Research Communications
|
May 15, 2024
Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein
Joseph P Gallant, Hallie M Hintz, Gihan S Gunaratne, et al.
Page
of 118
Search research articles
Search
Showing results (901-910 of 1,180) with videos related to
Sort By:
Page
of 118
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2015
The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer
Shuang G Zhao, Joseph R Evans, Vishal Kothari, et al.
Science (New York, N.Y.)
|
February 11, 2017
A switch from canonical to noncanonical autophagy shapes B cell responses
Nuria Martinez-Martin, Paula Maldonado, Francesca Gasparrini, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
G Akabani, I Cokgor, R E Coleman, et al.
Cancer
|
June 29, 2019
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database
Amandeep R Mahal, Santino Butler, Idalid Franco, et al.
NPJ Precision Oncology
|
October 2, 2024
A phenocopy signature of TP53 loss predicts response to chemotherapy
Hamza Bakhtiar, Marina N Sharifi, Kyle T Helzer, et al.
Oncogene
|
September 27, 2016
Cell cycle-coupled expansion of AR activity promotes cancer progression
C McNair, A Urbanucci, C E S Comstock, et al.
European Urology
|
June 2, 2018
The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer
Matthew R Cooperberg, Nicholas Erho, June M Chan, et al.
Molecular and Cellular Biochemistry
|
July 1, 1997
Construction of a human heart cDNA library and identification of cardiovascular based genes (CVBest)
C C Liew, D M Hwang, R X Wang, et al.
Prostate Cancer and Prostatic Diseases
|
May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer
S G Zhao, W C Jackson, V Kothari, et al.
Cancer Research Communications
|
May 15, 2024
Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein
Joseph P Gallant, Hallie M Hintz, Gihan S Gunaratne, et al.
Page
of 118